208A - Early phase clinical trials conducted in North America are more likely to exclude breast cancer patients based on organ function and comorbidities compared to other countries: Analysis of 484 studies
Autor: | Mariotti, V., Gonzalez Velez, M., Duma, N., Parrondo, R., Kothadia, S., Gladney, B., Panchal, R., Liu, J., Patel, K., Undamatla, R. |
---|---|
Zdroj: | In European Journal of Cancer February 2017 72 Supplement 1:S25-S25 |
Databáze: | ScienceDirect |
Externí odkaz: |